Literature DB >> 8225623

Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases.

V Schuster1, M Herold, H Wachter, G Reibnegger.   

Abstract

Serum levels of interferon gamma, interleukin-6 and neopterin were determined in 15 patients with different forms of Epstein-Barr virus-associated diseases: acute self-limiting infectious mononucleosis, chronic active infectious mononucleosis and X-linked lymphoproliferative syndrome. In patients with acute type of infection, neopterin, interferon gamma and interleukin-6 were elevated in nearly all patients. In contrast, the situation was less clear-cut in the other EBV-associated diseases; particularly interleukin-6 was undetectable in most cases. The results suggest that concomitant measurement of these diverse immune activation markers may provide interesting insights into the interactions between the virus and the host, and may also lead to therapeutic consequences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225623     DOI: 10.1007/bf01728890

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study.

Authors:  J Gosselin; L Flamand; M D'Addario; J Hiscott; I Stefanescu; D V Ablashi; R C Gallo; J Menezes
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

2.  Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

Authors:  B Klein; X G Zhang; M Jourdan; J Content; F Houssiau; L Aarden; M Piechaczyk; R Bataille
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

3.  High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis.

Authors:  P Chavanet; B Bonnotte; M Guiguet; V Zeller; E Solary; L Maurice; O Casasnovas; D Caillot; A Waldner; J P Kisterman
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

4.  Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.

Authors:  D Fuchs; T J Spira; A Hausen; G Reibnegger; E R Werner; G W Felmayer; H Wachter
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

5.  Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells.

Authors:  R J Bende; G J Jochems; T H Frame; M R Klein; R V van Eijk; R A van Lier; W P Zeijlemaker
Journal:  Cell Immunol       Date:  1992-09       Impact factor: 4.868

6.  Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1.

Authors:  D Fuchs; A Hausen; G Reibnegger; E R Werner; G Werner-Felmayer; M P Dierich; H Wachter
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

7.  Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha.

Authors:  J Gosselin; L Flamand; M D'Addario; J Hiscott; J Menezes
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome.

Authors:  A Linde; B Andersson; S B Svenson; H Ahrne; M Carlsson; P Forsberg; H Hugo; A Karstorp; R Lenkei; A Lindwall
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

9.  Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266.

Authors:  G Schwab; C B Siegall; L A Aarden; L M Neckers; R P Nordan
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

10.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Infectious mononucleosis complicated by acute hepatitis and myocarditis: a response to corticosteroids.

Authors:  Robin Ghosal; Keir E Lewis; Sriram Chandramouli
Journal:  BMJ Case Rep       Date:  2009-04-23

3.  Primary Epstein-Barr virus infection does not erode preexisting CD8⁺ T cell memory in humans.

Authors:  Oludare A Odumade; Jennifer A Knight; David O Schmeling; David Masopust; Henry H Balfour; Kristin A Hogquist
Journal:  J Exp Med       Date:  2012-03-05       Impact factor: 14.307

4.  Common Respiratory Tract Infections as Psychological Entities: A Review of the Mood and Performance Effects of Being Ill.

Authors:  Tania Mahoney; Peter Ball
Journal:  Aust Psychol       Date:  2011-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.